Cell Isolation Market

Industry Overview

The global cell isolation market expected to grow from USD 9.87 billion in 2023 to USD 17.43 billion by 2030 at a compound annual growth rate (CAGR) of 9.94% during the forecast period ranging from 2025 to 2030.

Cell isolation refers to the specific method of extraction of the specified cell inside the heterogeneous mixture to develop new therapies. Cell separation plays a crucial role in a wide range of applications such as biologics designing and development, in-vitro diagnostics, therapeutic protein production, and other research works.

The growth of the global cell isolation market is driven by the growing chronic and infectious diseases, ongoing government initiatives to improve the biotechnology industry, and tech developments and increasing investments by the manufacturers to create innovative products.

The high cost of the cell isolation instruments and the complexities involved in their operation are the significant factors that are hindering the growth of the cell isolation market worldwide. However, the market is presented with significant growth opportunities by the significant growth in cancer research, stem cell and regenerative medicine research.

Market Segmentation

Insight by Product

The global cell isolation market is segmented on the basis of product into consumables and instruments segments, where the former is further subdivided into beads, reagents, kits, media, and sera, and disposables and the instruments segment into magnetic-activated cell separator systems, centrifuges, filtration systems, and flow cytometers. Out of these two major segments, the consumables segment will account for the larger share in the market during the forecast period due to the rising investments by the manufacturing companies to develop more effective and advanced products. It is also attributed to the rise in the number of regulatory approvals and the growing government initiatives to promote cell-based research.

Insight by Cell Type

Based on cell type, the global cell isolation market is segregated into human cells and animal cells segments. Out of these two segments, the human cells segment, which is further subdivided into stem cells and differentiated cells, will account for a larger market share during the forecast period due to significant technological advancements and extensive use of isolated differentiated human cells in therapeutic, research, academics, and biopharmaceutical & biotechnology industries. It is also attuited to the rising focus on human stem cell isolation.

Insight by Technique

The global cell isolation market is divided on the basis of different techniques into centrifugation-based cell isolation, filtration-based cell isolation, and surface marker-based cell isolation segments. Out of these techniques, the centrifugation-based cell isolation segment will account for the largest share of the market during the forecast period due to higher adoption and use of this technique for manufacturing vaccines, antibodies, and enzymes. It is also attributed to the low cost of centrifugation technique.

Insight by Application

The global cell isolation market is segmented classicfied into biomolecule isolation, stem cell research, therapeutics, tissue regeneration, cancer research, and in-vitro diagnostics segments on the basis of application. Among all these different segmentations, it is the biomolecule isolation application segment that is expected to grow at a faster rate due to the growing company funding to develop newer and more effective biopharmaceutical products.

Insight by End User

The global cell isolation market is divided on the basis of the different end users into research laboratories and institutes, cell banks, hospitals, and diagnostic laboratories, and biotechnology and biopharmaceutical companies. Among all these end users, it is the hospitals and diagnostic laboratories segment that will grow at a faster rate due to the rise in the number of incidents of bacterial and viral infections.

Global Cell Isolation Market Report Coverage

Report Metric	Details
Historical Period	2018 - 2023
Base Year Considered	2024
Forecast Period	2025 - 2030
Market Size in 2023	U.S.D.  9.87 Billion
Revenue Forecast in 2030	U.S.D.  17.43 Billion
Growth Rate	9.94%
Segments Covered in the Report	By Product, By Cell Type, By Technique, By Application and By End User
Report Scope	Market Trends, Drivers, and Restraints; Revenue Estimation and Forecast; Segmentation Analysis; Impact of COVID-19; Companies’ Strategic Developments; Market Share Analysis of Key Players; Company Profiling
Regions Covered in the Report	North America, Europe, Asia-Pacific, Middle East, South America and Rest of the World

Industry Dynamics

Industry Trends

It is noticed that several companies within the industry are now undertaking innovative product development strategies and expanded their product offering. The researchers are also more focused now to investigate and comprehend novel infectious virus to discover diagnostic aids and therapies for it, which needs cell isolation.

Growth Drivers

The significant growth of the biotechnology and biopharmaceutical industries and the growing need and adoption of biopharmaceuticals is promoting the growth of the global cell isolation market. In addition, the development in the area of microfluidics is also promoting the growth of the cell isolation market. It is also attributed to the growing preference of personalized medicine and rising government funding and grants for cell-based research and rise in the number of regulatory approvals. Moreover, there is a growing adoption of cell isolation techniques and are used extensively to develop and manufacture biologics such as recombinant proteins and monoclonal antibodies, which also contribute largely to the growth of the global cell isolation market.

Challenges

The primary growth hindrance of the cell isolation market worldwide is the difficulties involved in the development process of reagents. In addition, the growing concern over ethical issues with respect to cell isolation of embryonic stem is also a major challenge to the growth of cell isolation market across the world. The strict regulatory measures and high standards along with the high capital requirement by the new entrants also prevents widespread market growth.

Opportunities

The opportunities for growth in the cell isolation market are presented by the growing demand for biotechnology and biopharmaceuticals R&D that uses cell isolation techniques to support drug discovery and therapeutic development. It is also attributed to technological developments and continual improvements in isolation methods which increases the specificity, efficiency, and scalability across a wide range of applications.

Geographic Overview

North America leads the cell isolation market with the largest share during the forecast period due to the growing incidents of infectious diseases and cancer. In addition, rapid technological advancements and the growth of the biotechnology and biopharmaceutical industries are also fueling the market growth in this region.

The Asia-Pacific market, on the other hand, is expected to grow at a faster rate during the projected period due to growing number of cancer as well as other infectious diseases. In addition, the growing government support and initiatives, rising preference of personalized medicine, and advanced healthcare infrastructure are also creating a positive impact on the growth of the cell isolation market in the region.

Competitive Insight

Key players in the cell isolation market are catering to the demand of these devices by investing in technologically advanced products in their product portfolio across the globe. In Danaher Corporation, Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., Becton, Dickinson, and Company, Miltenyi Biotec, Terumo Corporation, General Electric Company, Stemcell Technologies Inc., Merck KGaA, and Pluriselect Life Science are the key players offering cell isolation.

Danaher Corporation is an American global conglomerate founded by brothers Steven and Mitchell Rales in 1984. Company is headquartered in Washington, D.C. The company designs, manufactures, and markets medical, industrial, and commercial products and services.

Bio-Rad Laboratories, Inc. is an American developer and manufacturer of specialized technological products for the life science research and clinical diagnostics markets.

Recent Developments by Key Players

Bio-Rad Laboratories (a global leader in life science research and clinical diagnostics products) launched the ddSEQ Single-Cell 3' RNA-Seq Kit and complementary Omnition v1.1 analysis software for single-cell transcriptome and gene expression research.

Cell BioEngines, Inc., a clinical-stage biotechnology company focused on delivering stem cell and immune cell therapies to address blood and solid cancers, entered into an agreement with Miltenyi to develop and manufacture its expanded hematopoietic stem cell transplantation (HSCT) product for clinical use in hematology-oncology.

The Cell Isolation Market report offers a comprehensive market segmentation analysis along with an estimation for the forecast period 2025–2030.

Segments Covered in the Report

• By Product
  • Consumables
  • Instruments
• By Cell Type
  • Human cells
  • Animal cells
• By Technique
  • Centrifugation-based cell isolation
  • Filtration-based cell isolation
  • Surface marker-based cell isolation
• By Application
  • Biomolecule isolation
  • Stem cell research
  • Therapeutics
  • Tissue regeneration
  • Cancer research
  • Vitro diagnostics
• By End User
  • Research laboratories and institutes
  • Cell banks
  • Hospitals
  • Diagnostic laboratories
  • Biotechnology
  • Biopharmaceutical companies

Geographical Segmentation

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia-Pacific (APAC)
  • China
  • Japan
  • India
  • South Korea
  • Rest of Asia-Pacific
• Rest of the World (RoW)
  • Brazil
  • Saudi Arabia
  • South Africa
  • U.A.E.
  • Other Countries

Source: VynZ Research

Source: VynZ Research